Skip to main content

Table 2 MONARCC participating centres

From: MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)

MONARCC participating sites

Principal investigator

Austin Hospital

Heidelberg

Niall Tebbutt

Border Medical Oncology

Albury

Christopher Steer

Coffs Harbour Base Hospital

Coffs Harbour

Karen Briscoe

Flinders Medical Centre

Bedford Park

Chris Karapetis

The Queen Elizabeth Hospital

Woodville

Timothy Price

Royal Hobart Hospital

Hobart

Melanie Wuttke

Monash Medical Centre Clayton Campus

Clayton

Eva Segelov

The Tweed Hospital

Tweed Heads

Ratnesh Srivastav

Royal Brisbane and Women’s Hospital

Herston

Matthew Burge

Townsville Hospital (Teletrial site)

Townsville

 

Hervey Bay Hospital (Teletrial site)

Hervey Bay

 

ICON Cancer Centre North Lakes (Teletrial site)

North Lakes

 

St Vincents Hospital (Darlinghurst)

Darlinghurst

Subotheni Thavaneswaran

Sunshine Coast University Hospital

Birtinya

Alessandra Francesconi

Gold Coast University Hospital

Southport

Susan Caird

The Prince Charles Hospital

Chermside

Matthew Burge

Northern Cancer Institute

St Leonards

Nick Pavlakis

Nepean Hospital

Kingswood

Jennifer Shannon

Princess Alexandra Hospital

Woolloongabba

Rahul Ladwa

Sunshine Hospital

St Albans

Jeanne Tie

Shoalhaven Hospital

Nowra

Lorraine Chantrill